Sort   by:  
 Page size 
UnknownAdvances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms.
Not available
S-EPMC7080342 | biostudies-literature
UnknownEffect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients.
Not available
S-EPMC9304941 | biostudies-literature
UnknownInhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation.
Not available
S-EPMC4128726 | biostudies-literature
UnknownStrategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy.
Not available
S-EPMC7960621 | biostudies-literature
UnknownEpigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors.
Not available
S-EPMC10200989 | biostudies-literature
UnknownResident participation in neighbourhood audit tools - a scoping review.
Not available
S-EPMC5881759 | biostudies-literature
UnknownTargeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.
Not available
S-EPMC6338796 | biostudies-literature
UnknownPeptide Receptor Radionuclide Therapy.
Not available
S-EPMC9693835 | biostudies-literature
UnknownAberrant tryptophan metabolism in stromal cells is associated with mesenteric fibrosis in small intestinal neuroendocrine tumors.
Not available
S-EPMC9066570 | biostudies-literature
UnknownACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.
Not available
S-EPMC3847204 | biostudies-literature
Sort   by:  
 Page size